Cytomegalovirus (CMV) MicroRNA Expression in Vivo and Immune Evasion Correlates
Cytomegalovirus (CMV) microRNA Expression in Vivo and Immune Evasion Correlates
Sponsor: University of Alberta
A observational or N/A phase clinical study on Transplant, this trial is completed. The trial is conducted by University of Alberta and has accumulated 8 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jul 2022 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Jan 2021 — Jul 2022 [monthly]
Unknown Status
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
-
Jun 2017 — Apr 2018 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2017 — Jun 2017 [monthly]
Active Not Recruiting NA
First recorded
Apr 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Alberta
For direct contact, visit the study record on ClinicalTrials.gov .